News: Medicine

View:

2006

 

Found press releases

 

Micronic adjusts the assessment for sales 2006

12/21/2006 1:30 AM EST  -   Micronic
TABY, Sweden – December 21, 2006 – Micronic Laser Systems AB (Stockholm Exchange, Nordic list, Mid cap, Information technology: MICR), is a leading global supplier of laser pattern generators for photomasks.
The Board of Micronic has decided to revise its expectations for the full year sales. The Board’s earlier assessment was that sales for the full year would be in the range of SEK 1,300 to SEK 1,500 million....

Orexo submits registration application (IND) to FDA to complete the Phase III cl...

12/20/2006 2:00 AM EST  -   Orexo
Orexo AB has submitted a registration application to FDA to complete Orexo’s clinical Phase III program for the insomnia product Sublinox™ (OX 22) - Orexo´s patented product for treatment of temporary sleeping disturbances. The studies are expected to be completed in the second half of 2007. A registration application for the US and EU markets are estimated to be submitted at the end of 2007.

ACQUISITION OF SHARES IN HUNTLEIGH TECHNOLOGY PLC

12/19/2006 1:11 PM EST  -   Getinge Group
As previously announced, Getinge made a public tender offer on December 8 for all of the shares outstanding in the medical equipment company Huntleigh Technology Plc (“Huntleigh”), which is listed on the London Stock Exchange.

Getinge today acquired an additional 2,842,570 Huntleigh shares, corresponding to approximately 3.33% of the total number of Huntleigh shares. The consideration for these shares amounted to...

Orexo announces another agreement for its pain product Rapinyl™

12/19/2006 6:10 AM EST  -   Orexo
Orexo AB and the Hungarian pharmaceutical company Gedeon Richter Ltd. today announced that they have entered into a distribution agreement under which Gedeon Richter receives exclusive rights to market and sell Rapinyl™ – Orexo´s patented product for management of breakthrough cancer pain – in CIS, Bulgaria and Rumania. This is Orexo’s first distribution agreement for Rapinyl™. The marketing rights have previously...

First Danish CoroNet order

12/18/2006 4:56 AM EST  -   Ortivus
Ortivus will supply the research units of Skejby Hospital in Århus with special PCI monitors developed for use during artery surgery. Skejby Hospital becomes the first hospital in Denmark to install CoroNet, Ortivus’ specialized system for cardiac monitoring and will also serve as a reference site for Ortivus’ solutions for cardiac care. The system was sold through Ortivus’ Danish subsidiary and installation will...

ELEKTA’S NOMINATION COMMITTEE APPOINTED

12/14/2006 8:34 AM EST  -   Elekta
PRESS RELEASE Stockholm, Sweden, December 14, 2006 In accordance with the decision at the Annual General Meeting on September 20, 2006, Elekta’s Board Chairman Akbar Seddigh has during November and December contacted the company’s largest shareholders to form a Nomination Committee. Consequently, the shareholders agreeing to participate in the work of the Nomination Committee each nominated a representative.

ACQUISITION OF SHARES IN HUNTLEIGH TECHNOLOGY PLC

12/13/2006 1:38 PM EST  -   Getinge Group
Further to the announcement made on 8 December 2006 of a recommended cash offer by Getinge Extended Care UK Limited (the “Offeror”) (a wholly-owned subsidiary of Getinge AB (publ.)) for the acquisition of the entire issued and to be issued share capital of Huntleigh Technology PLC, including both the ‘A’ Ordinary Shares and the Ordinary Shares, the Offeror announces that it has acquired 15,516,717 ordinary shares in...

MEDA AB (PUBL): notification of extraordinary general meeting (EGM)

12/13/2006 12:30 PM EST  -   MEDA
Shareholders in Meda AB (publ), corporate ID 556427 2812 (hereafter the company), are hereby invited to attend an extraordinary general meeting (hereafter EGM) on Wednesday, 10 January 2007 at 4 PM in the company’s offices at Pipers väg 2A in Solna, Sweden.
Notification of attendance

To be entitled to participate in the meeting, shareholders must be listed as shareholders in the share register kept by VPC AB...

New share issue with preferential rights for existing shareholders in the amoun...

12/13/2006 12:00 PM EST  -   MEDA
• Share issue terms 1:9 at SEK 160
• Extraordinary General Meeting on 10 January 2007
On account of the earlier announced acquisition of 3M’s European pharmaceutical division the Board of Meda has decided on a new share issue with preferential rights for the Company’s shareholders in the amount of SEK 1,857 million – subject to approval by an Extraordinary General Meeting. The proceeds from the new share...

Six-month interim report May – October 2006/07

12/12/2006 7:00 AM EST  -   Elekta
• Order bookings rose 15 percent to SEK 2,302 M (1,997). Order backlog amounted to SEK 4,147 M, a record high level. • Net sales increased 4 percent to SEK 2,014 M (1,940). • Operating profit increased to SEK 159 M (153) and the operating margin was 8 percent (8). On a rolling 12-month basis, the operating margin was 10 percent. • Profit after taxes amounted to SEK 104 M (98). Earnings per share after dilution...